Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management

Benzer Materyaller

• Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation
  Yazar:: Pulsipher, Michael A., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study
  Yazar:: Seftel, Matthew D., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Bone Marrow: A Prespecified Analysis from the Phase III BMT CTN Protocol 0201
  Yazar:: Burns, Linda J., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• EBMT transplant centers with FACT-JACIE accreditation have significantly better compliance with related donor care standards
  Yazar:: Anthias, Chloe, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease and Search Prognosis
  Yazar:: Dehn, Jason, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)